ST-605 HSV keratitis phase 2 study

ST-605 uncontrolled open-label phase 2 study in patients with herpes simplex virus keratitis

Status

Recruiting

Phases

Phase 2

Study type

Interventional

Source

JPRN

Registry ID

JPRN-jRCT2080223845

Enrollment

Registered

2018-03-16

Start date

2018-03-16

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Herpes simplex virus keratitis

Interventions

investigational material(s) Generic name etc : ST-605 ophthalmic gel INN of investigational material : ganciclovir Therapeutic category code : 131 Agents for ophthalmic use Dosage and Administration f

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: 1) Patients who are diagnosed as HSV epithelial keratitis (dendritic or geographic keratitis) 2) Patients who are 18 years old or more 3) Patients who have informed consent

Exclusion criteria

Exclusion criteria:

Design outcomes

Primary

Measure	Time frame
Cure rate after treatment Slit-lamp examination	—

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026